Defective fatty acid-mediated β-cell compensation in Zucker diabetic fatty rats

Pathogenic implications for obesity-dependent diabetes

Hiroshi Hirose, Young H Lee, Lindsey R. Inman, Yoshitaka Nagasawa, John H. Johnson, Roger H Unger

Research output: Contribution to journalArticle

116 Citations (Scopus)

Abstract

Although obesity is associated with insulin resistance, most obese humans and rodents remain nonnoglycemic because of compensatory hyperinsulinemia. This has been attributed to β-cell hyperplasia and increased low Km glucose metabolism of islets. Since free fatty acids (FFA) can induce these same β-cell changes in normal islets of Wistar rats and since plasma FFA are increased in obesity, FFA could be the signal from adipocytes that elicits β-cell compensation sufficient to prevent diabetes. To determine if FFA-induced compensation is impaired in islets of rats with a diabetogenic mutation, the Zucker diabetic fatty (ZDF) rat, we cultured islets from 6-week-old obese (fa/fa) rats that had compensated for obesity and apparently normal islets from lean ZDF rats (fα/+) in 0, 1, or 2 mM FFA. Low Km glucose usage rose 2.5-fold in FFA-cultured control islets from age-matched Wistar rats, but failed to rise in either the precompensated islets of ZDF rats or in islets of lean ZDF rats. Bromodeoxyuridine incorporation increased 3.2-fold in Wistar islets but not in islets from obese or lean ZDF rats. Insulin secretion doubled in normal islets cultured in 2 mM FFA (p < 0.01) but increased only slightly in islets from lean ZDF rats (not significant) and declined in islets from obese ZDF rats (p < 0.05). We conclude that, unlike the islets of age-matched Wistar rats, islets of 6-week-old heterozygous and homozygous ZDF rats lack the capacity for FFA-induced enhancement of β-cell function.

Original languageEnglish (US)
Pages (from-to)5633-5637
Number of pages5
JournalJournal of Biological Chemistry
Volume271
Issue number10
StatePublished - Mar 8 1996

Fingerprint

Medical problems
Rats
Fatty Acids
Nonesterified Fatty Acids
Obesity
Wistar Rats
Compensation and Redress
Glucose
Hyperinsulinism
Insulin
Bromodeoxyuridine
Adipocytes
Hyperplasia
Insulin Resistance
Rodentia
Metabolism
Mutation

ASJC Scopus subject areas

  • Biochemistry

Cite this

Defective fatty acid-mediated β-cell compensation in Zucker diabetic fatty rats : Pathogenic implications for obesity-dependent diabetes. / Hirose, Hiroshi; Lee, Young H; Inman, Lindsey R.; Nagasawa, Yoshitaka; Johnson, John H.; Unger, Roger H.

In: Journal of Biological Chemistry, Vol. 271, No. 10, 08.03.1996, p. 5633-5637.

Research output: Contribution to journalArticle

@article{7a8f9de0cba74f3d95b25614e5e302c7,
title = "Defective fatty acid-mediated β-cell compensation in Zucker diabetic fatty rats: Pathogenic implications for obesity-dependent diabetes",
abstract = "Although obesity is associated with insulin resistance, most obese humans and rodents remain nonnoglycemic because of compensatory hyperinsulinemia. This has been attributed to β-cell hyperplasia and increased low Km glucose metabolism of islets. Since free fatty acids (FFA) can induce these same β-cell changes in normal islets of Wistar rats and since plasma FFA are increased in obesity, FFA could be the signal from adipocytes that elicits β-cell compensation sufficient to prevent diabetes. To determine if FFA-induced compensation is impaired in islets of rats with a diabetogenic mutation, the Zucker diabetic fatty (ZDF) rat, we cultured islets from 6-week-old obese (fa/fa) rats that had compensated for obesity and apparently normal islets from lean ZDF rats (fα/+) in 0, 1, or 2 mM FFA. Low Km glucose usage rose 2.5-fold in FFA-cultured control islets from age-matched Wistar rats, but failed to rise in either the precompensated islets of ZDF rats or in islets of lean ZDF rats. Bromodeoxyuridine incorporation increased 3.2-fold in Wistar islets but not in islets from obese or lean ZDF rats. Insulin secretion doubled in normal islets cultured in 2 mM FFA (p < 0.01) but increased only slightly in islets from lean ZDF rats (not significant) and declined in islets from obese ZDF rats (p < 0.05). We conclude that, unlike the islets of age-matched Wistar rats, islets of 6-week-old heterozygous and homozygous ZDF rats lack the capacity for FFA-induced enhancement of β-cell function.",
author = "Hiroshi Hirose and Lee, {Young H} and Inman, {Lindsey R.} and Yoshitaka Nagasawa and Johnson, {John H.} and Unger, {Roger H}",
year = "1996",
month = "3",
day = "8",
language = "English (US)",
volume = "271",
pages = "5633--5637",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "10",

}

TY - JOUR

T1 - Defective fatty acid-mediated β-cell compensation in Zucker diabetic fatty rats

T2 - Pathogenic implications for obesity-dependent diabetes

AU - Hirose, Hiroshi

AU - Lee, Young H

AU - Inman, Lindsey R.

AU - Nagasawa, Yoshitaka

AU - Johnson, John H.

AU - Unger, Roger H

PY - 1996/3/8

Y1 - 1996/3/8

N2 - Although obesity is associated with insulin resistance, most obese humans and rodents remain nonnoglycemic because of compensatory hyperinsulinemia. This has been attributed to β-cell hyperplasia and increased low Km glucose metabolism of islets. Since free fatty acids (FFA) can induce these same β-cell changes in normal islets of Wistar rats and since plasma FFA are increased in obesity, FFA could be the signal from adipocytes that elicits β-cell compensation sufficient to prevent diabetes. To determine if FFA-induced compensation is impaired in islets of rats with a diabetogenic mutation, the Zucker diabetic fatty (ZDF) rat, we cultured islets from 6-week-old obese (fa/fa) rats that had compensated for obesity and apparently normal islets from lean ZDF rats (fα/+) in 0, 1, or 2 mM FFA. Low Km glucose usage rose 2.5-fold in FFA-cultured control islets from age-matched Wistar rats, but failed to rise in either the precompensated islets of ZDF rats or in islets of lean ZDF rats. Bromodeoxyuridine incorporation increased 3.2-fold in Wistar islets but not in islets from obese or lean ZDF rats. Insulin secretion doubled in normal islets cultured in 2 mM FFA (p < 0.01) but increased only slightly in islets from lean ZDF rats (not significant) and declined in islets from obese ZDF rats (p < 0.05). We conclude that, unlike the islets of age-matched Wistar rats, islets of 6-week-old heterozygous and homozygous ZDF rats lack the capacity for FFA-induced enhancement of β-cell function.

AB - Although obesity is associated with insulin resistance, most obese humans and rodents remain nonnoglycemic because of compensatory hyperinsulinemia. This has been attributed to β-cell hyperplasia and increased low Km glucose metabolism of islets. Since free fatty acids (FFA) can induce these same β-cell changes in normal islets of Wistar rats and since plasma FFA are increased in obesity, FFA could be the signal from adipocytes that elicits β-cell compensation sufficient to prevent diabetes. To determine if FFA-induced compensation is impaired in islets of rats with a diabetogenic mutation, the Zucker diabetic fatty (ZDF) rat, we cultured islets from 6-week-old obese (fa/fa) rats that had compensated for obesity and apparently normal islets from lean ZDF rats (fα/+) in 0, 1, or 2 mM FFA. Low Km glucose usage rose 2.5-fold in FFA-cultured control islets from age-matched Wistar rats, but failed to rise in either the precompensated islets of ZDF rats or in islets of lean ZDF rats. Bromodeoxyuridine incorporation increased 3.2-fold in Wistar islets but not in islets from obese or lean ZDF rats. Insulin secretion doubled in normal islets cultured in 2 mM FFA (p < 0.01) but increased only slightly in islets from lean ZDF rats (not significant) and declined in islets from obese ZDF rats (p < 0.05). We conclude that, unlike the islets of age-matched Wistar rats, islets of 6-week-old heterozygous and homozygous ZDF rats lack the capacity for FFA-induced enhancement of β-cell function.

UR - http://www.scopus.com/inward/record.url?scp=0029920943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029920943&partnerID=8YFLogxK

M3 - Article

VL - 271

SP - 5633

EP - 5637

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 10

ER -